Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
3.600
+0.380 (11.80%)
At close: Nov 20, 2024, 4:00 PM
4.000
+0.400 (11.11%)
After-hours: Nov 20, 2024, 7:38 PM EST
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of $127.94 million as of November 21, 2024. Its market cap has increased by 8.76% in one year.
Market Cap
127.94M
Enterprise Value
118.19M
1-Year Change
8.76%
Ranking
Category
Stock Price
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from $61.62M to $127.94M, an increase of 107.64%. That is a compound annual growth rate of 21.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 127.94M | 15.41% |
| Dec 29, 2023 | 110.86M | 90.37% |
| Dec 30, 2022 | 58.23M | 111.19% |
| Dec 31, 2021 | 27.57M | -55.25% |
| Mar 9, 2021 | 61.62M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rani Therapeutics Holdings | 114.51M |
| Fennec Pharmaceuticals | 114.12M |
| Seres Therapeutics | 112.43M |
| Journey Medical | 112.03M |
| Adlai Nortye | 110.70M |
| Cidara Therapeutics | 108.66M |
| InflaRx | 107.46M |
| Adagene | 106.25M |